Medicated
OTC Healthcare > Medicated skin care

Medicated Skin Care in Italy

Italy

Euromonitor International's Medicated Skin Care in Italy market report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data, allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market - be they new product developments, packaging innovations, economic/lifestyle influences, distribution or pricing issues. Forecasts illustrate how the market is set to change.

Get immediate access to strategic market analysis when you buy reports online

Tables: 52  |  Publication date: Dec 2007
Cost: 
GBP450.00

Why buy this report

  • Get insight into trends in market performance
  • Pinpoint growth sectors and identify factors driving change
  • Identify market and brand leaders and understand the competitive environment

Product coverage

Acne treatments; Antiparasitics/lice (head and body) treatments; Antipruritics; Child-specific medicated skin care; Emollients/therapeutic moisturisers; Haemorrhoid treatments; Hair loss treatments; Lip care treatments; Medicated shampoos; Nappy (diaper) rash treatments; Topical allergy remedies/antihistamines; Topical antifungals; Topical germicidals/antiseptics; Vaginal antifungals

Table of contents

OTC HEALTHCARE IN ITALY : MARKET INSIGHT

EXECUTIVE SUMMARY

Modest growth in 2006

Self-medication ever more important

Best performer Whitehall Italia gains second position in 2006

Supermarkets to challenge pharmacy monopoly

Modest growth expected despite wider availability

KEY TRENDS AND DEVELOPMENTS

OTC Products on Supermarkets’ Shelves

Greying Population

Wellness Trend Affects OTC Medicines

The Importance of Health in Modern Lifestyles

Targeting Specific Segments

MARKET INDICATORS

Table 1 Life Expectancy at Birth 2001-2006

MARKET DATA

Table 2 Sales of OTC Healthcare by Sector: Value 2001-2006

Table 3 Sales of OTC Healthcare by Sector: % Value Growth 2001-2006

Table 4 OTC Healthcare Company Shares by Retail Value 2002-2006

Table 5 OTC Healthcare Brand Shares by Retail Value 2003-2006

Table 6 Penetration of Private Label by Sector 2002-2006

Table 7 Sales of OTC Healthcare by Distribution Format: % Analysis 2001/2006

Table 8 Sales of OTC Healthcare by Sector and Distribution Format: % Analysis 2006

Table 9 Forecast Sales of OTC Healthcare by Sector: Value 2006-2011

Table 10 Forecast Sales of OTC Healthcare by Sector: % Value Growth 2006-2011

APPENDIX

OTC Registration and Classification

Table 11 Number of Prescriptions Issued 2003-2006

De-listing Or De-reimbursement

Advertising

Packaging and waste

Labelling

Distribution

Vitamins and Dietary Supplements Registration and Classification

Generics

Consumer Expenditure on Health Goods and Medical Services

Table 12 Consumer Expenditure on Health Goods and Medical Services 2001-2006

DEFINITIONS

Sources

Summary 1 Research Sources

LOCAL COMPANY PROFILES - ITALY

A MENARINI INDUSTRIE FARMACEUTICHE RIUNITE SRL - OTC HEALTHCARE - ITALY

STRATEGIC DIRECTION

KEY FACTS

Summary 2 A Menarini Industrie Farmaceutiche Riunite Srl: Key Facts

Summary 3 A Menarini Industrie Farmaceutiche Riunite Srl: Operational Indicators

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

Summary 4 A Menarini Industrie Farmaceutiche Riunite Srl: Competitive Position 2006

AZIENDE CHIMICHE RIUNITE ANGELINI FRANCESCO ACRAF SPA - OTC HEALTHCARE - ITALY

STRATEGIC DIRECTION

KEY FACTS

Summary 5 Aziende Chimiche Riunite Angelini Francesco ACRAF SpA: Key Facts

Summary 6 Aziende Chimiche Riunite Angelini Francesco ACRAF SpA: Operational Indicators

COMPANY BACKGROUND

PRODUCTION

Summary 7 Aziende Chimiche Riunite Angelini Francesco ACRAF SpA: Production Statistics 2006

COMPETITIVE POSITIONING

Summary 8 Aziende Chimiche Riunite Angelini Francesco ACRAF SpA: Competitive Position 2006

BRACCO SPA - OTC HEALTHCARE - ITALY

STRATEGIC DIRECTION

KEY FACTS

Summary 9 Bracco SpA: Key Facts

Summary 10 Bracco SpA: Operational Indicators

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

Summary 11 Bracco SpA: Competitive Position 2006

CHIESI FARMACEUTICI SPA - OTC HEALTHCARE - ITALY

STRATEGIC DIRECTION

KEY FACTS

Summary 12 Chiesi Farmaceutici SpA: Key Facts

Summary 13 Chiesi Farmaceutici SpA: Operational Indicators

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

Summary 14 Chiesi Farmaceutici SpA: Competitive Position 2006

PERFETTI VAN MELLE SPA - OTC HEALTHCARE - ITALY

STRATEGIC DIRECTION

KEY FACTS

Summary 15 Perfetti Van Melle SpA: Key Facts

Summary 16 Perfetti Van Melle SpA: Operational Indicators

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

Summary 17 Perfetti Van Melle SpA: Competitive Position 2006

RECORDATI INDUSTRIA CHIMICA E FARMACEUTICA SPA - OTC HEALTHCARE - ITALY

STRATEGIC DIRECTION

KEY FACTS

Summary 18 Recordati Industria Chimica e Farmaceutica SpA: Key Facts

Summary 19 Recordati Industria Chimica e Farmaceutica SpA: Operational Indicators

COMPANY BACKGROUND

PRODUCTION

Summary 20 Recordati Industria Chimica e Farmaceutica SpA: Production Statistics 2006

COMPETITIVE POSITIONING

Summary 21 Recordati Industria Chimica e Farmaceutica SpA: Competitive Position 2006

SANOFI-AVENTIS SPA - OTC HEALTHCARE - ITALY

STRATEGIC DIRECTION

KEY FACTS

Summary 22 Sanofi-Aventis SpA: Key Facts

Summary 23 Sanofi-Aventis SpA: Operational Indicators

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

Summary 24 Sanofi-Aventis SpA: Competitive Position 2006

SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE SPA - OTC HEALTHCARE - ITALY

STRATEGIC DIRECTION

KEY FACTS

Summary 25 Sigma-Tau Industrie Farmaceutiche Riunite SpA: Key Facts

Summary 26 Sigma-Tau Industrie Farmaceutiche Riunite SpA: Operational Indicators

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

Summary 27 Sigma-Tau Industrie Farmaceutiche Riunite SpA: Competitive Position 2006

ZAMBON ITALIA SPA - OTC HEALTHCARE - ITALY

STRATEGIC DIRECTION

KEY FACTS

Summary 28 Zambon Italia SpA: Key Facts

Summary 29 Zambon Italia SpA: Operational Indicators

COMPANY BACKGROUND

PRODUCTION

Summary 30 Zambon Italia SpA: Production Statistics 2006

COMPETITIVE POSITIONING

Summary 31 Zambon Italia SpA: Competitive Position 2006

MEDICATED SKIN CARE IN ITALY

HEADLINES

TRENDS

COMPETITIVE LANDSCAPE

PROSPECTS

SECTOR DATA

Table 13 Sales of Medicated Skin Care by Subsector: Value 2001-2006

Table 14 Sales of Medicated Skin Care by Subsector: % Value Growth 2001-2006

Table 15 Herbal vs Standard Medicated Skin Care 2001/2006

Table 16 Medicated Skin Care Company Shares by Retail Value 2002-2006

Table 17 Medicated Skin Care Brand Shares by Retail Value 2003-2006

Table 18 Acne Treatments Brand Shares by Retail Value 2003-2006

Table 19 Hair Loss Treatments Brand Shares by Retail Value 2003-2006

Table 20 Forecast Sales of Medicated Skin Care by Subsector: Value 2006-2011

Table 21 Forecast Sales of Medicated Skin Care by Subsector: % Value Growth 2006-2011

Change currency displayed
all prices excluding P&P
request more information

Available formats

  • Instant online access
  • Download PDF
  • Download Word document
research methodology

Get Acrobat Reader

click here to download Adobe Acrobat Reader 7.0

© Euromonitor International 2008